Streptococcus thermophilus derived human CXCR3 gene target sequence recognizable by CRISPR (clustered regularly interspaced short palindromic repeat)-Cas9 (CRISPR associated 9) system and sgRNA (single guide ribonucleic acid) and application thereof
A technology of sequence recognition and system recognition, applied in the field of genetic engineering, can solve problems such as frameshift mutation, gene knockout, DNA insertion or deletion, etc., and achieve the effect of preventing and/or treating AIDS
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] This example is used to illustrate the design of the sgRNA of the present invention.
[0043] 63 sgRNAs were constructed according to the 5'-recognition sequence-recruiting Cas9 protein sequence-3' and the base sequence shown in Table 1 below.
[0044] Table 1
[0045]
Embodiment 2
[0047] This example is used to illustrate the construction of the CRISPR-Cas9 (CRISPR-St1Cas9) system of the present invention.
[0048] (1) Add CACC to the 5' end of the DNA sequence corresponding to the sgRNA (as shown in Example 1) to obtain a forward oligonucleotide (Forwardoligo). According to this sgRNA, its complementary strand is obtained, and at its 5' end Addition of AAAC results in a reverse oligonucleotide (Reverseoligo). synthesized separately. If the first base at the 5' end of the DNA sequence corresponding to the sgRNA recognition sequence is not G, you need to add a G after CACC, and correspondingly add a matching C at the 3' end of the reverse oligonucleotide. The above-mentioned forward oligonucleotide and reverse oligonucleotide are denatured and annealed in pairs, and after annealing, a double-stranded sgRNA oligonucleotide that can be connected to a U6 eukaryotic expression vector is formed. The denaturation and annealing system is:
[0049]
[0050]...
Embodiment 3
[0065] This example is used to illustrate the method of using the CRISPR-Cas9 system of the present invention to edit the CXCR4 gene.
[0066] (1) Cell culture and transfection
[0067] (1) HEK293T cells (CBR-130005, purchased from Shanghai Saiqi Bioengineering Co., Ltd.) were cultured in DMEM high-glucose medium (containing 10% FBS, penicillin (penicillin, 100U / ml) and streptomycin (streptomycin, 100μg / ml)) for cultivation;
[0068] (2) Divide into six-well plates before transfection, and perform transfection when the cell density reaches 70%;
[0069] (3) According to the dosage ratio of Lipofectamine3000 (Invitrogen, 11668-019), use 3 μg of U6-CXCR4sgRNA-EF1a-NLS-St1Cas9-NLS-2A-Puro-WPRE, or 1.5 μg of U6-CXCR4sgRNA-EF1a-Neo-WPRE and 1.5 μg of U6-EF1a-NLS-St1Cas9-NLS-2A-Puro-WPRE was combined to transfect each well of cells, and the medium was changed after 8 hours. Correspondingly, Puromycin (Puromycin) and G418 (Geneticin) were added for drug screening, 48 hours Cells ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com